Evofem Biosciences Total Assets 2013-2022 | EVFM

Evofem Biosciences total assets from 2013 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
Evofem Biosciences Annual Total Assets
(Millions of US $)
2021 $43
2020 $110
2019 $28
2018 $4
2017 $4
2016 $13
2015 $40
2014 $77
2013 $5
2012 $13
Evofem Biosciences Quarterly Total Assets
(Millions of US $)
2022-09-30 $42
2022-06-30 $53
2022-03-31 $35
2021-12-31 $43
2021-09-30 $67
2021-06-30 $109
2021-03-31 $93
2020-12-31 $110
2020-09-30 $112
2020-06-30 $135
2020-03-31 $16
2019-12-31 $28
2019-09-30 $39
2019-06-30 $54
2019-03-31 $3
2018-12-31 $4
2018-09-30 $15
2018-06-30 $26
2018-03-31 $9
2017-12-31 $4
2017-09-30 $6
2017-06-30 $8
2017-03-31 $11
2016-12-31 $13
2016-09-30 $15
2016-06-30 $23
2016-03-31 $26
2015-12-31 $40
2015-09-30 $53
2015-06-30 $64
2015-03-31 $72
2014-12-31 $77
2014-09-30 $0
2014-06-30 $0
2014-03-31 $0
2013-12-31 $5
2012-12-31 $13
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.007B $0.008B
Evofem Biosciences Inc. develops and anticipates commercializing products which support and promote women as the primary healthcare consumer. The company is identifying and developing new and novel products which specifically address unmet needs in the areas of sexual and reproductive health, the prevention of acquisition of sexually transmitted infections and products which address or promote general health and wellbeing. Evofem Biosciences Inc., formerly known as Neothetics Inc., is based in SAN DIEGO CA.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $158.293B 9.67
GSK (GSK) United Kingdom $71.300B 9.41
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.249B 19.20
Ginkgo Bioworks Holdings (DNA) United States $3.996B 0.00
Myovant Sciences (MYOV) United Kingdom $2.614B 0.00
Arcus Biosciences (RCUS) United States $1.485B 22.29
Biohaven (BHVN) United States $1.240B 0.00
Emergent Biosolutions (EBS) United States $0.697B 5.48
ADC Therapeutics SA (ADCT) Switzerland $0.356B 0.00
Enzo Biochem (ENZ) United States $0.070B 0.00
Ambrx Biopharma (AMAM) United States $0.070B 0.00
SQZ Biotechnologies (SQZ) United States $0.024B 0.00
Gelesis Holdings (GLS) United States $0.024B 0.00